|

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

RECRUITINGSponsored by N.N. Petrov National Medical Research Center of Oncology
Actively Recruiting
SponsorN.N. Petrov National Medical Research Center of Oncology
Started1998-09
Est. completion2030-12
Eligibility
Age1 Year+
Healthy vol.Accepted

Summary

The investigators will collect biosamples of patient blood and tumour tissue for further immunological analysis of blood cell subpopulations, immunosupressive factors concentration, HLA expression an lymphocytes and tumour tissue, and and cancer testis antigenes expression on tumour cells, as well as clinical data on patient's stage, therapy, response and demographics. Possible prognostic and predictive dynamic biomarkers will be discovered for individualisation of treatment strategies

Eligibility

Age: 1 Year+Healthy volunteers accepted
Inclusion Criteria:

* Signed inform consent
* Histolgically verified solid tumour
* Receiving systemic therapy for neoplasm
* Has archival tumour tissue
* Provide biosamples with living tumour tissue or blood samples for immunologic assessment

Exclusion Criteria:

* Concurrent Lymphoprolipherative disorder
* Patients after stem cell or bone marrow thansplantation
* Incomplete informaton on previous cancer history or medical history
* Patients with known primary immunodeficiency
* Patients receiving immunosupressive therapy for concurrent illness
* Pregnant patients

Conditions8

CancerColorectal CancerKidney CancerMalignant Solid TumorsMelanomaPrimary Brain TumorProstate CancerSoft Tissue Sarcoma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.